top of page

Leverage our Patented Technology

Patent Licensing of the  M5 iE  micro molding technology and process available for US companies.

Patent Licensing of the M5 iE micro molding technology and

process available to United States companies only.​


Click here to contact us


Molding multiple parts from one pellet's worth of plastic is a challenge that growing numbers of molders want to tackle. It is driving development of new technology in injection machines, tooling, parts handling, and inspection.


Business Case for M5 Micro MoldingTechnology:

There currently are no standard off-the-shelf injection molding machines available on the market that are capable of injection shot sizes less than .05-.015 grams, and at these shot weights, repeatability and residence times are often an issue.


There is a need for an injection molding machine that can mold micro sized parts (.0005-.1g) with minimal to zero runner waste.

Run your moldable materials efficiently.

  • API Resins

  • Bioresorbable

  • Fluoropolymers

  • Long Term Implantables

  • All Thermoplastic Resins

  • Liquid Silicone Rubber (LSR)

  • MIM (Cobalt Chrome • SST • Titanium) & others


M5 has development such a technology, that has been proven to work and is being used in commercial applications.


Click here to contact us    •    Heidenhain article about M5

Material cost savings

Screenshot 2023-02-23 at 6.56.03 PM.png



M5 iE (intelligent energy)

High Performance Desktop Micro Molding Platform

• Direct Cavity Injection  

• Fully Automatable

• Near Zero Material Waste

• Fast Rapid prototyping iterations

• Machine Footprint 9” x 22” x 22”

• Mold Head 9” x 4” x 4” 

• Mold head can run remote from machine base


Late 2015

First test of micro molding head and open platform.


Rev I - ENCLOSED PLATFORM - Cooling External

Rev II - Auto Mold

Rev III - Actuating Arms - External

Rev IV - Cooling System - Internal


Rev V - All Internal

Rev A - Production Platform Ready for launch!!


Build multiple units for internal micro molding contracts

Running multiple projects internal @ M5


Running multiple projects internal @ M5


Patent issued!


Ready for Patent licensing.


The Global Orthopedic Biomaterials Market size is expected to reach $20.4 billion by 2025, rising at a market growth of 10.2% CAGR during the forecast period.

The global implantable biomaterials market size is expected to 
grow from $101.91 billion in 2021 to $113.64 billion in 2022 at a compound annual growth rate (CAGR) of 11.5%. The global implantable biomaterial market size is expected to grow to $180.87 billion in 2026 at a CAGR of 12.3%.


The global PEEK is projected to be worth USD 1,225.7 Million by  2027 growing at a CAGR OF 6.8%

See report here.

Automation Cell w/ 4 Micro Molding Heads

Our patented micro molding technology and processes are both small in size and highly flexible. Our technology can be used in many different applications, and with all moldable materials, like in the automation cell video.

As you can see in the video, we have 4 mold heads inside of the automation cell.

bottom of page